Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02244554 · ClinicalTrials.gov registry record · NA

Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal

A NA study, sponsored by Cutera.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT02244554: Completed NA study, sponsored by Cutera.

NCT02244554 is a NA study that has completed, run by Cutera. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02244554, a NA study, has completed, sponsored by Cutera.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and efficacy of laser tattoo removal with picosecond pulse durations as compared to treatment with nanosecond pulse durations using a single novel Q-Switched (QS) Nd:YAG laser.

Primary Outcome

Physician's Global Assessment (min=0; Max=4) Higher scores indicate better outcomes

Interventions

  • DEVICE enLighten Laser

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-07
Est. Completion 2016-03
Phase NA
Cutera

37 total trials

What the finished NCT02244554 record still lists

NCT02244554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which enLighten Laser is the first listed.

NCT02244554 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02244554 about?

NCT02244554 is a clinical study titled "Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal". The purpose of this study is to evaluate the safety and efficacy of laser tattoo removal with picosecond pulse durations as compared to treatment with nanosecond pulse durations using a single novel Q-Switched (QS) Nd:YAG laser.

What is the current status of trial NCT02244554?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-07. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02244554?

The interventions under investigation include: enLighten Laser (DEVICE).

Who is sponsoring clinical trial NCT02244554?

This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02244554's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02244554, the US trial registry maintained by the National Library of Medicine. NCT02244554 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.